Neoadjuvant gemcitabine,docetaxel, and capecitabine followed by gemcitabine and capecitabine/radiation therapy and surgery in locally advanced,unresectable pancreatic adenocarcinoma期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Neoadjuvant gemcitabine,docetaxel, and capecitabine followed by gemcitabine and capecitabine/radiation therapy and surgery in locally advanced,unresectable pancreatic adenocarcinoma

Authors:	William H. Sherman MD Kyung Chu NP John Chabot MD John Allendorf MD Beth Ann Schrope MD Elizabeth Hecht MD Brian Jin MD David Leung MD PhD Helen Remotti MD Gisella Addeo MD Inna Postolov MD Wei Tsai PhD Robert L. Fine MD

Affiliation:	1. Pancreas Center, Columbia University, New York, New York;2. Department of Medicine, New York University, New York, New York;3. Department of Surgery, Columbia University, New York, New York;4. Department of Surgery, Winthrop University Hospital, Mineola, New York;5. Department of Radiology, Columbia University, New York, New York;6. Department of Pathology, Columbia University, New York, New York;7. Department of Radiation Oncology, Columbia University, New York, New York;8. Department of Biostatistics, Columbia University, New York, New York;9. Department of Medicine, Columbia University, New York, New York

Abstract:

Keywords:	capecitabine docetaxel gemcitabine pancreatic cancer radiation therapy